Back to search
FDAFDA · Food and drugs·Recall number D-0481-2017

Transderm Scop (scopolamine) Transdermal System, 1.5 mg, 1 patch per pouch (NDC 66758-208-58), packaged in 4-count patches per carton (NDC 66758-208-54), Rx Only, Manufactured by ALZA Corporation, Vacaville, CA 95688 for Sandoz Inc., Princeton, NJ 08540.

Published March 1, 2017 · Recall initiated: February 2, 2017

Summary

FDA records drug Class II recall D-0481-2017, published March 1, 2017 and initiated February 2, 2017. Recalling firm: Sandoz Inc; Status: Terminated; Reported quantity: 157,922 cartons; Lot: Lot #: 6323Q11, 6328Q11, Exp 06/19; 6355Q11, Exp 07/19. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Incorrect Instructions:outer carton contains the incorrect instructions for Step 2 stating "Do cut the patch" rather than the correct instructions of "Do not cut the patch". The pouch containing the patch is labeled correctly.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Sandoz Inc
Distributor
Nationwide in the USA and Puerto Rico
Lot
Lot #: 6323Q11, 6328Q11, Exp 06/19; 6355Q11, Exp 07/19
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Transderm Scop (scopolamine) Transdermal System, 1.5 mg, 1 patch per pouch (NDC 66758-208-58), packaged in 4-count patches per carton (NDC 66758-208-54), Rx Only, Manufactured by ALZA Corporation, Vacaville, CA 95688 for Sandoz Inc., Princeton, NJ 08540. recalled?

Yes. FDA published recall D-0481-2017 on March 1, 2017. Reported hazard: Labeling: Incorrect Instructions:outer carton contains the incorrect instructions for Step 2 stating "Do cut the patch" rather than the correct instructions of "Do not cut the patch". The pouch containing the patch is labeled correctly.

What should I do if I have this product?

Voluntary: Firm initiated · Letter